2 results  1 of 1 

1 Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma
Do-Young Kim, Moo-Kon Song, Joo-Seop Chung, Ho-Jin Shin, Deok Hwan Yang, Sung-Nam Lim, Sung-Yong Oh
Blood Res.2019;54(4):244-252.   Published online 2019 December 20     DOI: http://dx.doi.org/10.5045/br.2019.54.4.244
      
2 The Modified Glasgow Prognostic Scores as a Predictor in Diffuse Large B Cell Lymphoma Treated with R-CHOP Regimen
Yundeok Kim, Soo Jeong Kim, Dohyu Hwang, Jieun Jang, Shin-Young Hyun, Yu Ri Kim, Jin Seok Kim, Yoo Hong Min, June-Won Cheong
Yonsei Med J.2014;55(6):1568-1575.   Published online 2014 October 8     DOI: http://dx.doi.org/10.3349/ymj.2014.55.6.1568
      

 1 of 1